Pharmacies in all ten provinces are now providing first and second doses as provincial reopening plans hinge on vaccination rates and the country tries to stay a step ahead of the Delta variant.
Pfizer has announced the start of a large study to test the safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in children below the age of 12 years.
